Coloplast A/s Class B · OMXCOP:COLO_B

Coloplast A/s Class B — H1 2015/16 Earnings Presentation

7 slides from Coloplast A/s Class B's earnings presentation, May 3, 2016

  1. Slide 1: Coloplast Earnings Conference Call H1 2015/16

    Coloplast Earnings Conference Call H1 2015/16 3 May 2016

  2. Slide 2: Forward-looking statements

    Forward-looking statements The forward-looking statements contained in this presentation, including forecasts of sales and earnings performance, are not guarantees of future results and are subject to risks, uncertainties and assumptions that are difficult to predict. The forward-looking statements

  3. Slide 3: H1 15/16 organic growth of 7% and 33% EBIT margin

    H1 15/16 organic growth of 7% and 33% EBIT margin Highlights Performance  Organic revenue growth of 7% (8% in DKK) Revenue (mDKK)  Gross margin of 68% compared with 69% Organic growth (%) for the same period last year  EBIT margin of 33%, both in DKK and 12.000 7 7 10 11.000 10.000 constant excha

  4. Slide 4: H1 15/16 organic growth was 7% against a market growth of ~5%

    H1 15/16 organic growth was 7% against a market growth of ~5% H1 15/16 revenue by business area H1 15/16 revenue by geography Business Reported revenue Organic growth Geographic Reported revenue Organic growth area mDKK In percent area mDKK In percent Ostomy 8% European 5% 2,898 4,586 Care markets C

  5. Slide 5: Operating margin of 33% impacted by efficiency gains, higher Emerging markets costs and increased R&D activity

    Operating margin of 33% impacted by efficiency gains, higher Emerging markets costs and increased R&D activity Comments Performance  EBIT grew 7% to DKK 2,361m with a margin of EBIT (mDKK) 33% in H1 EBIT margin (%)  Q2 EBIT margin of 32%  Gross margin of 68% compared to 69% last Gross margin (%)

  6. Slide 6: Financial guidance for 2015/16 – revised expectations for sales growth in DKK and capex

    Financial guidance for 2015/16 – revised expectations for sales growth in DKK and capex Guidance Guidance Long term 15/16 15/16 (DKK) ambition Sales growth 7-8% (organic) 6-7% 7-10% p.a. EBIT margin 33-34% (fixed) ~33% +50-100 bps p.a. CAPEX (DKKm) 600-700 ~4-5% of sales Tax rate ~23% - Page 6

  7. Slide 7: Our mission, values and vision

    Our mission Making life easier for people with intimate healthcare needs Our values Closeness… to better understand Passion… to make a difference Respect and responsibility… to guide us Our vision Setting the global standard for listening and responding Page 7

Coloplast — H1 2015/16 Earnings Presentation on 6ix